These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 19789590

  • 1. The treatment of wet AMD in Canada: access to therapy (policy review).
    Cruess A, Maberley D, Wong D, Chen J.
    Can J Ophthalmol; 2009 Oct; 44(5):548-56. PubMed ID: 19789590
    [Abstract] [Full Text] [Related]

  • 2. Burden of illness of neovascular age-related macular degeneration in Canada.
    Cruess A, Zlateva G, Xu X, Rochon S.
    Can J Ophthalmol; 2007 Dec; 42(6):836-43. PubMed ID: 18026200
    [Abstract] [Full Text] [Related]

  • 3. New treatments for age-related macular degeneration.
    Mittra RA.
    Minn Med; 2003 Apr; 86(4):40-6. PubMed ID: 12797657
    [Abstract] [Full Text] [Related]

  • 4. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y.
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [Abstract] [Full Text] [Related]

  • 5. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL.
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [Abstract] [Full Text] [Related]

  • 6. New treatments for age-related macular degeneration.
    Mittra RA, Ramsay RC.
    Minn Med; 2009 Jun; 92(6):41-4. PubMed ID: 19653472
    [Abstract] [Full Text] [Related]

  • 7. [Treatment according to "evidence-based medicine" of aged-related exudative age-related macular degeneration (laser photocoagulation and photodynamic therapy)].
    Donati G.
    Klin Monbl Augenheilkd; 2001 May; 218(5):313-5. PubMed ID: 11417324
    [Abstract] [Full Text] [Related]

  • 8. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
    Verma L, Das T, Binder S, Heriot WJ, Kirchhof B, Venkatesh P, Krebs I, Stolba U, Jahn C, Feichtinger H, Kellner L, Krugluger H, Pawelka I, Frohner U, Kruger A, Li W, Tewari HK.
    Indian J Ophthalmol; 2000 Dec; 48(4):263-78. PubMed ID: 11340884
    [Abstract] [Full Text] [Related]

  • 9. [Progression of treatment and researches in dry age related macular degeneration].
    Zhang K, Tang S.
    Zhonghua Yan Ke Za Zhi; 2015 Mar; 51(3):236-40. PubMed ID: 26268648
    [Abstract] [Full Text] [Related]

  • 10. Socioeconomic status and clinical features of patients undergoing photodynamic therapy or transpupillary thermotherapy for subfoveal choroidal neovascularization due to age-related macular degeneration.
    Chew H, Maberley DA, Ma P, Chang A, Maberley A.
    Can J Ophthalmol; 2005 Jun; 40(3):384-8. PubMed ID: 15947808
    [Abstract] [Full Text] [Related]

  • 11. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F, Lafuma A, Berdeaux G.
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
    [Abstract] [Full Text] [Related]

  • 12. Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.
    Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monès J, Xu X, Zlateva G, Buggage R, Conlon J, Goss TF.
    Arch Ophthalmol; 2007 Sep; 125(9):1249-54. PubMed ID: 17846366
    [Abstract] [Full Text] [Related]

  • 13. Wet age-related macular degeneration.
    Kulkarni AD, Kuppermann BD.
    Adv Drug Deliv Rev; 2005 Dec 13; 57(14):1994-2009. PubMed ID: 16309781
    [Abstract] [Full Text] [Related]

  • 14. [The treatment of the exsudative age-related macular degeneration with choroidal neovascular membrane, its possibilities and economical indexes].
    Karel I.
    Cesk Slov Oftalmol; 2007 Sep 13; 63(5):311-9. PubMed ID: 17915581
    [Abstract] [Full Text] [Related]

  • 15. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL, Yu F.
    Ophthalmology; 2008 Jan 13; 115(1):18-25. PubMed ID: 17572499
    [Abstract] [Full Text] [Related]

  • 16. Effect of quercetin on formation of choroidal neovascularization (CNV) in age-related macular degeneration(AMD).
    Zhuang P, Shen Y, Lin BQ, Zhang WY, Chiou GC.
    Eye Sci; 2011 Mar 13; 26(1):23-9. PubMed ID: 21425492
    [Abstract] [Full Text] [Related]

  • 17. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller JA, Handa JT, Nguyen QD, Sung JU.
    Hum Gene Ther; 2001 Nov 01; 12(16):2029-32. PubMed ID: 11727737
    [Abstract] [Full Text] [Related]

  • 18. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.
    Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J, Vision Health Cost-Effectiveness Study Group.
    Arch Ophthalmol; 2009 Apr 01; 127(4):533-40. PubMed ID: 19365036
    [Abstract] [Full Text] [Related]

  • 19. AMD--the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics.
    Nowak JZ.
    Acta Pol Pharm; 2014 Apr 01; 71(6):900-16. PubMed ID: 25745762
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of exudative age-related macular degeneration].
    Yuzawa M.
    Nippon Ganka Gakkai Zasshi; 2000 Dec 01; 104(12):875-98. PubMed ID: 11193943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.